Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study.

Autor: Ozonoff A; Clinical & Data Coordinating Center (CDCC), Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA., Jayavelu ND; Benaroya Research Institute, Seattle, WA, USA., Liu S; Clinical & Data Coordinating Center (CDCC), Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA., Melamed E; The University of Texas at Austin, Austin, TX, USA., Milliren CE; Clinical & Data Coordinating Center (CDCC), Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA., Qi J; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Geng LN; Stanford University, Stanford, CA, USA., McComsey GA; Case Western Reserve University and University Hospitals of Cleveland, Cleveland, OH, USA., Cairns CB; Drexel University/Tower Health Hospital, Philadelphia, PA, USA., Baden LR; Boston Clinical Site: Precision Vaccines Program, Boston Children's Hospital, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA., Schaenman J; David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA., Shaw AC; Yale School of Medicine, and Yale School of Public Health, New Haven, CT, USA., Samaha H; Emory University, Atlanta, GA, USA., Seyfert-Margolis V; MyOwnMed, Inc, Bethesda, MD, USA., Krammer F; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Rosen LB; National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, MD, USA., Steen H; Boston Clinical Site: Precision Vaccines Program, Boston Children's Hospital, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA., Syphurs C; Clinical & Data Coordinating Center (CDCC), Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA., Dandekar R; University of California San Francisco School of Medicine, San Francisco, CA, USA., Shannon CP; Centre for Heart Lung Innovation, Providence Research, St. Paul's Hospital, and the PROOF Centre of Excellence, Vancouver, BC, Canada., Sekaly RP; Case Western Reserve University and University Hospitals of Cleveland, Cleveland, OH, USA., Ehrlich LIR; The University of Texas at Austin, Austin, TX, USA., Corry DB; Baylor College of Medicine, and the Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey VA Medical Center, Houston, TX, USA., Kheradmand F; Baylor College of Medicine, and the Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey VA Medical Center, Houston, TX, USA., Atkinson MA; University of Florida/University of South Florida, Tampa, FL, USA., Brakenridge SC; University of Florida/University of South Florida, Tampa, FL, USA., Higuita NIA; Oklahoma University Health Sciences Center, Oklahoma City, OK, USA., Metcalf JP; Oklahoma University Health Sciences Center, Oklahoma City, OK, USA., Hough CL; Oregon Health & Science University, Portland, OR, USA., Messer WB; Oregon Health & Science University, Portland, OR, USA., Pulendran B; Stanford University, Stanford, CA, USA., Nadeau KC; Stanford University, Stanford, CA, USA., Davis MM; Stanford University, Stanford, CA, USA., Sesma AF; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Simon V; Icahn School of Medicine at Mount Sinai, New York, NY, USA., van Bakel H; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Kim-Schulze S; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Hafler DA; Yale School of Medicine, and Yale School of Public Health, New Haven, CT, USA., Levy O; Boston Clinical Site: Precision Vaccines Program, Boston Children's Hospital, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA., Kraft M; University of Arizona, Tucson, AZ, USA., Bime C; University of Arizona, Tucson, AZ, USA., Haddad EK; Drexel University/Tower Health Hospital, Philadelphia, PA, USA., Calfee CS; University of California San Francisco School of Medicine, San Francisco, CA, USA., Erle DJ; University of California San Francisco School of Medicine, San Francisco, CA, USA., Langelier CR; University of California San Francisco School of Medicine, San Francisco, CA, USA., Eckalbar W; University of California San Francisco School of Medicine, San Francisco, CA, USA., Bosinger SE; Emory University, Atlanta, GA, USA., Peters B; La Jolla Institute for Immunology, La Jolla, CA, USA., Kleinstein SH; Yale School of Medicine, and Yale School of Public Health, New Haven, CT, USA., Reed EF; David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA., Augustine AD; National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, MD, USA., Diray-Arce J; Clinical & Data Coordinating Center (CDCC), Precision Vaccines Program, Boston Children's Hospital, Boston, MA, USA., Maecker HT; Stanford University, Stanford, CA, USA., Altman MC; Benaroya Research Institute, Seattle, WA, USA., Montgomery RR; Yale School of Medicine, and Yale School of Public Health, New Haven, CT, USA., Becker PM; National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, MD, USA., Rouphael N; Emory University, Atlanta, GA, USA. nroupha@emory.edu.

Publikováno v: Nature communications [Nat Commun] 2024 Jan 03; Vol. 15 (1), pp. 216. Date of Electronic Publication: 2024 Jan 03.

Early and Limited Use of Tacrolimus to Avoid Rejection in an Alemtuzumab and Sirolimus Regimen for Kidney Transplantation: Clinical Results and Immune Monitoring

Autor: Knechtle, S.J. ^*, Pascual, J., Bloom, DD., Torrealba, J.R., Jankowska-Gan, E., Burlingham, W.J., Kwun, J., Colvin, R.B., Seyfert-Margolis, V., Bourcier, K., Sollinger, H.W.

Publikováno v: In American Journal of Transplantation May 2009 9(5):1087-1098

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Novel Approaches to Allergen Immunotherapy for Respiratory Allergies.

Autor: Lao-Araya, Mongkol¹ (AUTHOR) laoaraya@gmail.com

Publikováno v: Pharmaceuticals (14248247). Nov2024, Vol. 17 Issue 11, p1510. 20p.

Monitoring patients with juvenile idiopathic arthritis using health-related quality of life.

Autor: Doeleman MJH; Department of Pediatric Immunology and Rheumatology, Wilhelmina Children's Hospital, University Medical Center Utrecht, P.O. Box 85090, 3508, AB, Utrecht, The Netherlands. m.j.h.doeleman@umcutrecht.nl.; Faculty of Medicine, Utrecht University, Utrecht, The Netherlands. m.j.h.doeleman@umcutrecht.nl., de Roock S; Department of Pediatric Immunology and Rheumatology, Wilhelmina Children's Hospital, University Medical Center Utrecht, P.O. Box 85090, 3508, AB, Utrecht, The Netherlands.; Faculty of Medicine, Utrecht University, Utrecht, The Netherlands., Buijsse N; Department of Pediatric Immunology and Rheumatology, Wilhelmina Children's Hospital, University Medical Center Utrecht, P.O. Box 85090, 3508, AB, Utrecht, The Netherlands.; Faculty of Medicine, Utrecht University, Utrecht, The Netherlands., Klein M; Department of Pediatric Immunology and Rheumatology, Wilhelmina Children's Hospital, University Medical Center Utrecht, P.O. Box 85090, 3508, AB, Utrecht, The Netherlands., Bonsel GJ; The EuroQol Research Foundation, Rotterdam, The Netherlands.; Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands., Seyfert-Margolis V; MyOwnMed Inc., Bethesda, MD, USA., Swart JF; Department of Pediatric Immunology and Rheumatology, Wilhelmina Children's Hospital, University Medical Center Utrecht, P.O. Box 85090, 3508, AB, Utrecht, The Netherlands.; Faculty of Medicine, Utrecht University, Utrecht, The Netherlands., Wulffraat NM; Department of Pediatric Immunology and Rheumatology, Wilhelmina Children's Hospital, University Medical Center Utrecht, P.O. Box 85090, 3508, AB, Utrecht, The Netherlands.; Faculty of Medicine, Utrecht University, Utrecht, The Netherlands.

Publikováno v: Pediatric rheumatology online journal [Pediatr Rheumatol Online J] 2021 Mar 22; Vol. 19 (1), pp. 40. Date of Electronic Publication: 2021 Mar 22.